Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences EPS Diluted (TTM): 0.2677 for June 30, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.2677 |
| March 31, 2023 | 0.9738 |
| December 31, 2022 | 0.018 |
| September 30, 2022 | -1.331 |
| June 30, 2022 | 13.08 |
| March 31, 2022 | 5.852 |
| December 31, 2021 | 3.209 |
| September 30, 2021 | -5.779 |
| June 30, 2021 | -32.90 |
| March 31, 2021 | -32.77 |
| December 31, 2020 | -36.13 |
| September 30, 2020 | -15.27 |
| June 30, 2020 | -17.53 |
| March 31, 2020 | -69.62 |
| December 31, 2019 | -310.96 |
| September 30, 2019 | -1259.67 |
| June 30, 2019 | -1512.42 |
| March 31, 2019 | -1753.74 |
| December 31, 2018 | -1820.38 |
| September 30, 2018 | -1100.03 |
| June 30, 2018 | -997.21 |
| March 31, 2018 | -992.56 |
| December 31, 2017 | -977.91 |
| September 30, 2017 | -1208.52 |
| June 30, 2017 | -1355.66 |
| Date | Value |
|---|---|
| March 31, 2017 | -1368.72 |
| December 31, 2016 | -1285.24 |
| September 30, 2016 | -985.41 |
| June 30, 2016 | -831.57 |
| March 31, 2016 | -683.83 |
| December 31, 2015 | -707.55 |
| September 30, 2015 | -381.90 |
| June 30, 2015 | -596.42 |
| March 31, 2015 | -67.12 |
| December 31, 2014 | -6.252 |
| September 30, 2014 | -277.41 |
| June 30, 2014 | -6.295 |
| March 31, 2014 | -470.69 |
| December 31, 2013 | -325.81 |
| September 30, 2013 | -202.08 |
| June 30, 2013 | -5.415 |
| March 31, 2013 | 111.10 |
| December 31, 2012 | 47.82 |
| September 30, 2012 | 28.09 |
| June 30, 2012 | -174.44 |
| March 31, 2012 | -296.53 |
| December 31, 2011 | -298.10 |
| September 30, 2011 | -405.55 |
| June 30, 2011 | -399.64 |
| March 31, 2011 | -296.33 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-1512.42
Minimum
Jun 2019
13.08
Maximum
Jun 2022
-192.41
Average
-15.27
Median
Sep 2020
EPS Diluted (TTM) Benchmarks
| Acasti Pharma Inc | -4.578 |
| Aurinia Pharmaceuticals Inc | -0.53 |
| Edesa Biotech Inc | -2.639 |
| Lexaria Bioscience Corp | -0.68 |
| Xenon Pharmaceuticals Inc | -2.72 |